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GYPC encodes two erythrocyte surface sialoglycoproteins in humans, glycophorin C and glycophorin D (GPC and
GPD), via initiation of translation at two start codons on a single transcript. The malaria-causing parasite Plasmodium
falciparum uses GPC as a means of invasion into the human red blood cell. Here, we examine the molecular evolution of
GYPC among the Hominoidea (Greater and Lesser Apes) and also the pattern of polymorphism at the locus in a global
human sample. We ﬁnd an excess of nonsynonymous divergence among species that appears to be caused solely by
accelerated evolution of GYPC in the human lineage. Moreover, we ﬁnd that the ability of GYPC to encode both GPC
and GPD is a uniquely human trait, caused by the evolution of the GPC start codon in the human lineage. The pattern of
polymorphism among humans is consistent with a hitchhiking event at the locus, suggesting that positive natural
selection affected GYPC in the relatively recent past. Because GPC is exploited by P. falciparum for invasion of the red
blood cell, we hypothesize that selection for evasion of P. falciparum has caused accelerated evolution of GYPC in
humans (relative to other primates) and that this positive selection has continued to act in the recent evolution of our
species. These data suggest that malaria has played a powerful role in shaping molecules on the surface of the human red
bloodcell.Inaddition,ourexaminationofGYPCrevealsanovelmechanismofproteinevolution:co-optionofuntranslated
region (UTR) sequence following the formation of a new start codon. In the case of human GYPC, the ancestral protein
(GPD) continues to be produced through leaky translation. Because leaky translation is a widespread phenomenon among
genes and organisms, we suggest that co-option of UTR sequence may be an important source of protein innovation.
Introduction
The malaria-causing parasite Plasmodium falciparum
utilizes multiple molecular pathways for invasion of human
erythrocytes (Gaur et al. 2004). Underlying these diverse
methods of entry is the ability of parasites to bind to the
cell via numerous receptor–ligand interactions (Adams
et al. 2001). Several distinct molecules comprise the human
ligands targeted during invasion, including Glycophorins
A, B, and C (encoded by GYPA, GYPB, and GYPC, respec-
tively), as well as other unidentiﬁed players (Corte ´s 2008).
Elucidating the molecular evolution of these molecules is
critical to understanding the historical coevolutionary inter-
actions between humans and P. falciparum and the origins
of human alleles that provide resistance to malarial disease.
In a comparison of 280 human gene sequences with
their orthologs in Old World monkeys, Wang et al.
(2003) identiﬁed GYPA, GYPB, and GYPE (the latter
encodes Glycophorin E, which currently has no known role
in erythrocyte invasion by Plasmodium) as having among
the highest rates of nonsynonymous evolution. These genes
share signiﬁcant homology and likely arose through dupli-
cation events in the primate lineage (Rearden et al. 1993;
Onda and Fukuda 1995; Wang et al. 2003). The high rate
of evolution of the glycophorins has been explained by two
competing hypotheses. In their examination of GYPA,
Baum et al. (2002) proposed the ‘‘decoy’’ hypothesis,
whereby the extracellular components of erythrocytic
sialoglycoproteins bind with and sequester nonerythrocytic
intracellular pathogens (e.g., bacteria and viruses), thereby
preventing their invasion of nucleated cells. Baum et al.
(2002) suggest that species-speciﬁc pathogen pressures
result in high rates of nonsynonymous divergence between
species and maintenance of high levels of polymorphism
within species. Wang et al. (2003) offer an alternative
‘‘evasion’’ hypothesis that proposes that the rapid evolution
of glycophorins is in response to Plasmodium pathogens
that recognize these molecules for entry into the erythro-
cyte. Coevolution between Plasmodium receptors and their
glycophorin ligands on the human erythrocyte is proposed
to drive the rapid evolution of glycophorin-encoding genes.
The observation that segregating variants at P. falciparum
genes encoding erythrocyte receptors have dramatically
different sialoglycoprotein-binding speciﬁcities provides
support for the evasion hypothesis (Mayer et al. 2002,
2004).
To date, analyses of the molecular evolution and pop-
ulation genetics of sialoglycoprotein-encoding genes have
largelyignoredGYPC.Inpart,thismaybebecause thegene
didnotemergeasoneoftheveryrapidlyevolvinglociiden-
tiﬁed in the Wang et al. (2003) survey. GYPC is unique
among the glycophorin genes in two respects: First, its
sequence is not homologous to any other gene, whereas
GYPA,GYPB,andGYPEareallparalogous.Second,GYPC
encodes two distinct sialoglycoproteins, Glycophorin C
(GPC) and Glycophorin D (GPD), through initiation of
translation at two separate start sites within a single mRNA
transcript, as shown in ﬁgure 1 (Tanner et al. 1988; Le Van
Kimetal.1996).OnlyGPCisknowntoplayaroleineryth-
rocyte invasion by P. falciparum; this interaction is medi-
ated through the parasite’s EBA140 (BAEBL) receptor
(Maier et al. 2003). This distinction between GPC and
GPD with respect to EBA140 binding likely is due to an
N-linked glycan that modiﬁes GPC (but not GPD) and is
necessary for receptor recognition (Mayer et al. 2006).
GYPC is also of interest because an allele encoding
a structural variant segregates at high frequencies among
Melanesians and is responsible for the Gerbich-negative
(Ge ) phenotype (Booth and McLoughlin 1972). This
allele contains a large deletion that eliminates the third exon
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of both GPC and GPD (Serjeantson et al. 1994). Ge  is
common enough to result in large numbers of homozygous
individuals in affected populations; these individuals often
exhibit erythrocyte ovalocytosis with no clinical symptoms
(Patel et al. 2001, 2004). Importantly, P. falciparum
EBA140doesnotbindtoGe cells,indicatingthatfeatures
of the peptide sequence in the deleted region are critical for
parasite recognition (Mayer et al. 2002, 2006; Maier et al.
2003).Mayeretal.(2006)suggestthatinteractionsbetween
the peptide backbone and an N-linked glycan may be crit-
ical for proper exposure of the ligand recognized by
EBA140. From an evolutionary perspective, the failure
of EBA140 to bind with Ge  cells suggests that the
Ge  phenotype may be maintained in populations through
malaria selection.
Our study examines the molecular evolution of GYPC
in the Hominoidea, as well as patterns of polymorphism
within human populations. Our goal is to test whether an
elevated rate of amino acid evolution exists at this gene.
If so, we will investigate whether this signature is restricted
to the human linage (consistent with recent adaptive
evolution mediated by P. falciparum or another species-
speciﬁc parasite) and/or restricted to extracellular regions
of the protein (where interactions with P. falciparum or
other parasites might occur). By examining human poly-
morphism in a global diversity panel, we will test whether
there is a signature of recent natural selection at the GYPC
locus (either in the form of positive selection increasing the
frequency of a single allele or diversity-maintaining selec-
tion favoring the presence of many alleles).
Materials and Methods
Biological Materials
Nonhuman primate DNA samples were obtained from
the Integrated Primate Biomaterials Resource. These in-
cluded samples from ﬁve species: common chimpanzee
(Pan troglodytes), bonobo (Pan paniscus), gorilla (Gorilla
gorilla), orangutan (Pongo pygmaeus), and white-cheeked
gibbon (Nomascus leucogenys). In addition, DNA from
50 human individuals, representing a global sample of di-
versity (including 20 sub-Saharan Africans, 10 Europeans,
5 Middle Easterners, 10 Asians, 3 Oceanians, and 2 Native
Americans) was obtained from the Coriell Cell Repository;
speciﬁc sample identities are detailed in Supplementary
Material online. A whole-blood sample from a single
P. troglodytes individual was obtained from the Yerkes Pri-
mateCenter. Whole-bloodfrom asinglehuman samplewas
obtained via venipuncture from a single subject. Human
blood collection was obtained with prior informed consent
and all human-subject protocols were approved by appro-
priate institutional review boards.
DNA Sequencing
Wesequencedthenucleotideregionencompassingthe
entire protein-coding segment of GYPC in all human and
nonhuman samples (adjacent intron sequence was also
examined for polymorphism in our human samples, as de-
scribed in Results). Diploid sequence data were produced
by direct sequencing of amplicons with overlapping
primers on both strands. Primers used for ampliﬁcation
and sequencing are available from the authors on request.
Sequences were assembled and variable sites identiﬁed us-
ing the program Sequencher v. 4.7 (GeneCodes).
Western Blotting
To investigate the protein products encoded by GYPC
in humans and P. troglodytes, we used an immunoblotting
procedure to stain GPC and GPD. We sampled 15 ml of
whole heparinized blood from a single human and chim-
panzee and prepared erythrocyte ghosts using a cell lysis
procedure (Schwoch and Passow 1973; Hanahan and
Ekholm 1974). Diluted membranes were run on a 15%
Tris–glycine sodium dodecyl sulfate polyacrylamide gel,
transferred to a nitrocellulose membrane, and treated with
a 1:1,000 dilution of primary antibody. This antibody was
monoclonal mouse antihuman CD236 (AbD Serotec),
which recognizes a 17 amino acid motif in the fourth exon
of GYPC (King et al. 1995). This motif is shared by GPC
and GPD and is completely conserved between our human
and P. troglodytes samples (as determined via DNA
sequencing, data not shown). After primary incubation,
the blot was treated with a 1:2,500 dilution of secondary an-
tibody, rabbit F(ab#)2 antimouse IgG:HRP (AbD Serotec)
and visualized using a GE Healthcare immunodetection
kit.
DNA Sequence Analyses
PAML Analyses
We used the program ‘‘codeml’’ in the software pack-
age Phylogenetic Analysis by Maximum Likelihood v. 4.2a
(PAML; Yang 2007) to ﬁt models of sequence evolution to
our Hominoidea data set (GYPC sequence from all ﬁve
nonhuman primates, plus a single human sequence). This
procedure requires speciﬁcation of a phylogenetic tree.
In our analyses, we implemented a standard unrooted Hom-
inoidea phylogeny, shown in ﬁgure 2A. Initial branch
lengths were estimated for this tree using PAML model
0 (M0), which estimates a single ratio of nonsynonymous
to synonymous evolution (the dN/dS ratio, or x) that applies
to all sites in all taxa.
To test for positive selection using PAML, we used
two separate classes of evolutionary models. The ﬁrst class
FIG. 1.—Structure of human GYPC. The proteins GPC and GPD are
encoded via initiation of translation at separate start codons in exons 1
and 2, respectively (coding exons are indicated by tall boxes, untranslated
region by short boxes, and introns by lines). The gene is drawn to scale,
except that exons 1 and 2 are separated by an intron that is approximately
34 kb in length.
2680 Wilder et al.includes the ‘‘site models,’’ where codon sites are allowed
to fall into categories that differ with respect to their x
values.Thesevaluesapplytoallbranchesofthephylogeny.
The second class of models are the ‘‘branch-site’’ models,
which are similar to the site models in that different codons,
can havedifferent xvalues; however, thephylogenyissplit
into ‘‘foreground’’ and ‘‘background’’ branches that contain
categories of sites with different x values. Of the site mod-
els, we examined several, which differ in the number of
classes of sites, to test for positive selection. First, we com-
pared the likelihood values associated with a ‘‘Nearly Neu-
tral’’ model (M1a) and a ‘‘Positive Selection’’ model (M2a),
originally described in Wong et al. (2004). Brieﬂy, M1a
assumes all codon sites fall into two classes, x1 and w0,
with a single value of x describing each class (equal to
1 in the former, and free to vary below 1 in the latter).
Model M2a adds an additional site class that is free to vary
above one. In both models, the proportion of sites falling
into each class is free to vary. The likelihood values asso-
ciated with the data under the two models were compared
using likelihood ratio tests, as described in Yang et al.
(2000). In addition to M1a and M2a, we examined several
additional site models, M7, M8, and M8a. Model M7 is
similar to model M1a except that the sites affected by neg-
ative selection (x , 1) approximate a beta distribution with
parameters (p and q) estimated from the data. M8 is related
to M7 in the same way that M2a is related to M1a—an
additional class of sites is added to M8 that is affected
by positive selection (x . 1). Models M7 and M8 were
initially described by Yang et al. (2000). A ﬁnal model,
M8a, forms an alternative null model to compare
with M8 (Swanson et al. 2003). Model M8a is identical
to M8, but the x value for the positively selected class
is ﬁxed at 1. Likelihood ratio tests were used to compare
M8 with M8a and M7, as described by Swanson et al.
(2003) and Wong et al. (2004). The posterior probabilities
associated with speciﬁc codons falling into a site class af-
fected by positive selection (in models M8 and M2a) was
calculated using the Bayes empirical Bayes (BEB) method
described by Yang et al. (2005). These methods were ap-
plied to several different partitions of the data, as described
in the Results section.
Toexaminewhetherhumansarecharacterizedbyadif-
ferent pattern of molecular evolution at GYPC compared
with the rest of the Hominoidea, we used a pair of
‘‘branch-site models.’’ In these models, the branch of the
phylogeny leading to humans was classiﬁed as the fore-
ground branch and all others as ‘‘background branches.’’
We used the branch-site test of selection developed by
Zhang et al. (2005) to test for positive selection acting
on a subset of sites in the human lineage. This test allows
for two categories of sites affected by positive selection
(x . 1) in the foreground, together with a category of sites
affected by negative selection (x , 1) and a neutrally
evolving class of sites (x 5 1). The background branches
contain sites in only the latter two classes. Likelihood val-
ues associated with this model are estimated and compared
with a null model in which both foreground and back-
ground branches contain only sites where x   1. In the null
model, foreground branches can have a higher fraction of
neutrally evolving sites (x 5 1) than background branches,
making this test of selection robust to a relaxation of con-
straints in the foreground branches. Likelihood values for
the two models were compared as described in Zhang et al.
(2005). As with the site models, maximum likelihood
estimates of data parameters are generated from the data.
Similarly,themethodgeneratesBEBposteriorprobabilities
associated with particular sites falling into the positively
selected class.
In all PAML analyses, codons containing alignment
gaps due to insertion–deletion events among species were
treated as missing data and not considered in pairwise
FIG. 2.—(A) Translation initiation regions of GPC and GPD. The GPC start codon (boxed) is present only in humans, whereas the GPD start codon
is conserved across all Apes. Starred sites denote loci important for efﬁcient recognition of the start codon by the ribosome; translation is typically most
efﬁcient when there is a purine at position  3 (which is true for GPC and GPD), and a G at position þ1 (which is true only for GPD). (B) Western
blotting of GYPC products in human and chimpanzee. Using an antibody recognizing an epitope shared by GPC and GPD, and exactly conserved
between humans and chimpanzee, we detect both proteins in human erythrocyte ghosts (Hs) but only GPD in chimpanzee (Pt).
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other species did not.
Polymorphism Analyses
In our human polymorphism data set (2n5100),
diploid sequence was arbitrarily phased and intron–exon
boundaries annotated. We employed several measures of
polymorphism and tests of neutrality using the program
DNAsp v.4.50.3 (Rozas et al. 2003). These included two
estimates of the population-mutation parameter (h), includ-
ing Watterson’s (1975) method (hW), which is based on the
number of segregating sites in a sample, and p, which is the
average number of pairwise differences between sequences
in a sample (Nei and Li 1979). Tests of selection included
three that examine the frequency spectrum of mutations,
Tajima’s (1989) D (TD), Fu and Li’s (1993) D (FLD), and
Fay and Wu’s (2000) H (FWH). Signiﬁcance of these tests
was assessed via coalescent simulations, implemented in
DNAsp. We also performed a McDonald–Kreitman (1991)
test, which examines the numbers of synonymous and non-
synonymous substitutions between species and polymorphic
sites withinspecies.For all testsrequiring outgroup informa-
tion, data from a single P. troglodytes were used.
Results
We sequenced the complete coding region of GYPC in
six Hominoidea species. These data revealed that the trans-
lation start site associated with GPC is present in humans
but not other taxa. This is due to a C to A transversion that
createdanoveltranslationstartcodoninhumans.Thetrans-
lation start site used to encode GPD is well conserved
among all taxa. Sequence data associated with the two start
codons are shownin ﬁgure2A.These data strongly suggest
that only humans encode two protein products (GPC and
GPD) at the GYPC gene. Western blotting of human and
P. troglodytes erythrocyte ghosts conﬁrms that the latter
encodesonlyasingleproteinproductofGYPC,conforming
in size to GPD (ﬁg. 2B).
Nonsynonymous and Synonymous Evolution
Because only humans have the ability to produce
GPC, we deﬁne the shared coding region among taxa in
our sample as only the portion of GYPC that encodes
GPD. Limiting our analysis to this region, examination
of nonsynonymous and synonymous evolution using
PAML suggests that the gene has been subject to positive
selection among the Hominoidea. Analyses of the entire
gene (and including all six taxa) using site models suggest
that models incorporating positive selection (M2a and M8)
are signiﬁcantly better ﬁts to the data than models including
only purifying selection and neutrally evolving sites (M1a,
M7, and M8a); these results are shown in table 1 (a mul-
tispecies alignment showing all data considered in PAML
analyses is included in supplementary ﬁgure 1, Supplemen-
tary Material online). When we remove from exon 3 our
analysis, the portion of the gene that when deleted in hu-
mans confers resistance to malaria (the Ge  phenotype),
we observe that models including positive selection no lon-
ger provide better ﬁtstothedatathannearlyneutralmodels.
Finally, when we remove humans from the data set and
reperform our analysis on the full gene from the ﬁve re-
maining Hominoidea, we see that models incorporating
positive selection are not better ﬁts to the data than nearly
neutral models. This implies that positive selection may be
limited to only the human lineage. The results of the
‘‘branch-site’’test bolster this inference. In thistest, amodel
allowing positive selection in only the human lineage is
a signiﬁcantly better ﬁt to the data than a model in which
all branches of the phylogeny are allowed to evolve with x
 1(table2).Thebranch-sitetestofpositiveselectionisnot
signiﬁcant when any other single branch of the phylogeny
is elevated to the foreground (data not shown).
Tables 1 and 2 show that a relatively small proportion
of sites within GYPC appear to be affected by positive se-
lection. Analysis of the entire gene under the site model
suggests 3.5% of codons are targeted by selection but that
selection affecting this class of sites is quite strong (x 5
21.88). The branch-site models suggest an even smaller
fraction of sites are targets of positive selection in the hu-
man lineage (1.2%) but that these sites are affected by very
strong positive selection (a speciﬁc value of x could not be
estimated—a result that is likely affected by the small num-
ber of sites in the analysis). Results of the BEB analysis in
both the site and branch-site models suggest that codons
affected by positive selection all fall within the third exon
of GYPC (ﬁg. 3). In particular, all models provide strong
support for the 27th codon falling into the selected site class
(posterior probability . 0.99); the site models (M2a and
M8) provide moderate support for the 24th and 26th codons
falling into this class (posterior probability . 0.80).
Polymorphism within Humans
To examine variation in a human sample, we rese-
quenced 1,235 bp of GYPC from 50 individuals (2n 5
100). This comprised the entire coding region of the gene
(387 bp), plus noncoding DNA adjacent to each exon (exon
1 region: 50 bp 5# untranslated region (UTR), 49 bp exon,
242 bp intron; exon 2 region: 57 bp exon, 218 bp intron;
exon 3 region: 84 bp exon, 220 bp intron; exon 4: 197 bp
exon, 118 bp 3# UTR). Our survey uncovered nine segre-
gating sites, all of which lie within or adjacent to exons 2, 3,
and 4. Genotype data for the 50 samples are shown in ac-
companying supplementary ﬁgure 2, Supplementary Mate-
rial online. Of the nine sites that vary, one is a synonymous
variant within the coding region, seven are polymorphisms
in noncoding DNA, and one is a nonsynonymous polymor-
phism. A McDonald–Kreitman test revealed no signiﬁcant
deviations from expected patterns under neutrality (8 silent
and 1 nonsynonymous polymorphic sites, 24 silent and 12
nonsynonymous substitutions; P 5 0.249 byFisher’s Exact
test). In contrast, one test of neutrality based on the fre-
quency spectrum of mutations shows signiﬁcant departures
from standard neutral expectations (table 3). Speciﬁcally,
Fay and Wu’s H (5  3.79) describes an excess of high
frequency–derived alleles in the data set; Tajima’s D and
Fu and Li’s D, in contrast, do not deviate from expected
2682 Wilder et al.patterns under neutrality. Signiﬁcance values reported in
table 3 are taken from simulations of the coalescent process
that do not incorporate recombination; these values are con-
servative relative to simulations conditioned on nonzero
values of recombination.
Discussion
GYPC is a rapidly evolving gene that has been subject
to positive natural selection in the human lineage. Our data
suggest that diversifying selection has caused rapid amino
acid evolution in a portion of the gene (the third exon) that
islikelytoaffectPlasmodiuminvasionoftheredbloodcell.
Our data also reveal the unexpected result that humans have
evolvedanovel startcodonupstreamoftheancestral GYPC
translation initiation site. This new start codon is ﬁxed in
our global human sample and allows humans to encode
two proteins, GPC and GPD, from a single transcript.
DNA sequence and protein immunoblotting data conﬁrm
that all other sampled Apes encode only GPD at this locus.
Our data have important implications with respect to under-
standing the forces driving sialoglycoprotein evolution and
the coevolutionary interactions between humans and
malaria-causing parasites. Moreover, our data point to
a novel evolutionary pathway by which protein innovation
occurs.
Positive Selection at GYPC
GYPC sequence data from the Hominoidea indicate
that the locus is subject to higher rates of amino acid
evolutioninthehumanlineagethanexpectedunderneutral-
ity. Whenweexaminethetotaldatasetfrom sixspecies,we
ﬁnd that site models of DNA sequence evolution that
Table 1
PAML-Implemented Site Models of Positive Selection
Model
a ln L Parameter Estimates
b Selected Codons
c
All species, full gene
M1a  679.00
M2a  673.02* p0 5 0.436 (x0 5 0.032), p1 5 0.529,
p2 5 0.035 (x2 5 21.88)
24 (0.82), 27 (0.99), 36 (0.88)
M7  679.12
M8A  678.99
M8  673.06* p0 5 0.44 (p 5 0.02, q 5 0.01),
p2 5 0.035 (x2 5 21.39)
24 (0.85), 27 (0.99), 36 (0.91)
All species, exon 3 excluded
M1a  413.81 p0 5 0.876 (x0 5 0.209), p1 5 0.124
M2a  413.80
M7  413.71 p 5 0.758, q 5 1.756
M8a  413.71 p0 5 0.999 (p 5 0.747, q 5 1.725), p1 5 0.001
M8  413.71
Human excluded, full gene
M1a  619.31 p0 5 0.389 (x0 5 0.0), p1 5 0.611
M2a  618.26
M7  619.32 p 5 0.008, q 5 0.005
M8a  619.31 p0 5 0.389 (p 5 0.005, q 5 1.554),
p1 5 0.611
M8  618.26
*P , 0.05, comparing model including positive selection (M2a or M8) to nearly neutral model (M1a, M7, or M8a).
a All models and comparisons among models are described in the text. Asterisks indicate comparisons where models that incorporate a class of sites affected by positive
selection are better ﬁts to the data than nearly neutral models (Models M2a and M8 in the ‘‘all species, full gene’’ comparison); in all other comparisons, models
incorporating positive selection are not better ﬁts to the data than nearly neutral models.
b Parameter abbreviations are as follows: p0 5 proportion of sites falling into nearly neutral site class (followed by estimate of x0 for models M1a and M2a or shape
parameters of the beta distribution (p,q) for models M7, M8a, and M8), p1 5 proportion of sites falling into neutral site class (x1 5 1); p2 5 proportion of sites falling into
positively selected site class (followed by estimate of x2).
c BEB estimates of sites falling into positively selected class are listed for those where the posterior probability (in parentheses) is greater than 0.8.
Table 2
PAML-Implemented Branch-Site Tests of Positive Selection
Model ln L Parameter Estimates Selected Codons
Anull  679.00 Foreground: p0 5 0.458 (x0 5 0.0), p1 5 0.542
Background: p0 5 0.458 (x0 5 0.0), p1 5 0.542
A  673.08* Foreground: p0 5 0.415 (x0 5 0.0),
p1 5 0.573, p2 5 0.012 (x2 5 inﬁnite)
27 (0.99)
Background: p0 5 0.420 (x0 5 0.0), p1 5 0.580
NOTE.—Models are as discussed in text; parameters are as described in table 1. Foreground branch includes the branch leading to humans, background branches include
all other branches of the Hominoidea phylogeny. On the foreground branch in Model A, two classes of selected sites (x . 1) are possible (as described in Materials and
Methods); however, only one class is populated in the present analysis.
*P , 0.05, comparing model A with Anull.
Molecular Evolution of GYPC 2683include a class of positively selected codons are signiﬁ-
cantly better ﬁts to the data than models that do not. This
result is dependent on inclusion of humans in the sequence
analysis, suggesting that positive selection may be
restricted to just the branch of the Hominoidea phylogeny
leading to humans. We have tested this hypothesis by per-
forming a branch-site test of accelerated evolution on the
human lineage. This test conﬁrms that models of sequence
evolution in which only human GYPC harbors a class of
sites affected by positive selection are better ﬁts to the data
than models where all branches of the phylogeny are evolv-
ing under purifying selection and/or neutrality. Because the
null model inthislatter test allows forhuman GYPCtohave
sites characterized by higher (but  1) x values than other
branches of the phylogeny, this test conﬁrms that human
GYPC has experienced accelerated amino acid evolution
due to positive selection, not a relaxation of selective
constraints.
In both the site and branch-site models of GYPC
sequenceevolution,theprincipaltargetofpositiveselection
appears to be regions of the gene encoding extracellular
protein components (ﬁg. 3). All sites identiﬁed through
BEB analysis as candidate targets of positive selection fall
within the third exon of the gene, corresponding to the
region that is deleted in the malaria-resistant Ge  allele
in humans. Exclusion of the third exon of the gene from
our PAML analyses eliminates any suggestion in the data
thatGYPChasbeensubjecttopositiveselection.Thisresult
indicates that only a small portion of the gene has been tar-
geted by positive selection and that sequence encoding
intramembrane and intracellular protein regions are evolv-
ing under the constraints of purifying selection and/or
neutrality.
Complementing the long-term positive selection indi-
cated by interspecies comparisons, our human GYPC poly-
morphism data suggest that a recent genetic hitchhiking
event has affected the locus in Homo sapiens. Speciﬁcally,
our data show an excess of polymorphic sites with high
frequency–derived alleles (indicated by a signiﬁcantly neg-
ative value of FWH) over neutral expectations. This pattern
is consistent with a selected allele being driven to very high
frequency at the locus in the relatively recent past. Our fail-
ure to observe signiﬁcant skews in the allele frequency
spectrum using TD and FLD does not contradict our inter-
pretation of signiﬁcant FWH values. Each of these tests has
limited power to detect natural selection, and their sensitiv-
ity to different aspects of the data make them complemen-
tary (Fay and Wu 2000; Przeworski 2002). Analysis of our
data using a McDonald–Kreitman test also reveals no
FIG. 3.—Putative selectedcodonswithinGYPC.Theposteriorprobabilityofeachcodonhavinganx.1isshownforthosewithaprobability.0.5
(values taken from the BEB analysis performed under PAML model M2a for the full data set). Extracellular, transmembrane, and cytosolic regions of the
encodedproteinareshown.Thedottedlineshowsthelocationoftheexon3deletion,whichsegregatesinhumanpopulationsandishypothesizedtoconfer
resistance to falciparum malaria; bases upstream of the dotted line fall within exon 2 and downstream bases fall within exon 4.
Table 3
Summary Statistics Describing Polymorphism at Human
GYPC
S 9
hW (%) 0.141
p (%) 0.096
TD  0.792 P 5 0.247
FWH  3.788 P 5 0.015
FLD  1.749 P 5 0.118
NOTE.—P values indicate probability of observing a smaller value based on
neutral coalescent simulations.
2684 Wilder et al.departures from neutral expectations. This latter test can
lack power to detect recent positive selection because silent
and replacement sites tightly linked to a target of selection
will experience a reduction in variation during a selective
sweep (Nielsen 2005).
The interpretation of a high frequency of derived
alleles in our polymorphism survey is complicated by
the fact that we sampled humans sparsely from a large num-
ber of populations. The presence of population structure in
polymorphism data can affect the site frequency spectrum
(Ptak and Przeworski 2002; Hammer et al. 2003). FWH, in
particular, has been shown to be sensitive to population
subdivisionunderanislandmodel whendemes aresampled
unequally (Przeworski 2002; Zeng et al. 2006). Because of
this, further surveys of polymorphism in individual popu-
lations will help to clarify the extent to which hitchhiking
events have affected GYPC. If the observed skew in the site
frequencyis,infact,causedbyrecentnaturalselection,then
we predict that that the hitchhiking event must have
occurred relatively recently because an excess of high fre-
quency alleles is expected to be a highly transient signature
of recent positive selection (Kim and Stephan 2000, 2002;
Przeworski 2002).
What Drives Positive Selection at GYPC?
OurresultssuggestthatGYPChasbeenatargetofpos-
itiveselectioninhumansoverbothshortandlongtimeframes
(i.e., recently enough to be evident in the pattern of poly-
morphism within humans and also over timescales long
enough to result in an excess of amino acid substitutions
between humans and related species). We propose that
our data are broadly consistent with selection mediated by
P.falciparumaspredictedbytheevasionhypothesis(Wang
et al. 2003). In the case of GYPC, selection for evasion has
been limited tothehuman lineage andiscoincidentwiththe
evolution of a new protein product (GPC) at the locus. Be-
cause there is no evidence that the ancestral GYPC protein
product (GPD) interacts with P. falciparum it is likely that
GYPC has been subject to malaria-related selection only
sincetheGPCstartcodonevolved.Subsequenttothisevent,
rapidevolutionofextracellularaminoacidresiduesencoded
byGYPCmayhaveoccurredinthehumanlineagetomitigate
erythrocyteinvasionbyP.falciparum.Indeed,severalstud-
ies have shown that P. falciparum EBA140 genotype vari-
ation correlates with the ability of this receptor to bind
with human GPC (Mayer et al. 2002, 2006; Maier et al.
2009), consistent with rapid coevolution of GYPC and its
P. falciparum receptor. Under our proposed model, the
evolutionary forces favoring the initial evolution of the
GPC start codon remain unclear. It may have arisen by drift
inanonmalarialancestralpopulationorhavebeenfavoredby
unknown selective forces.
Because our data suggest that accelerated amino acid
evolution is restricted to the human lineage, we believe
GYPC evolution is not well explained by the ‘‘decoy’’
hypothesis. Decoy-driven positive selection at GYPA was
hypothesized on the basis of high diversity within human
populations coupled with high x values in many primate
lineages (Baum et al. 2002). The broad phylogenetic distri-
bution of rapid amino acid evolution at GYPA is potentially
compatible with a generalized decoy function of Glyco-
phorin A. In the case of human GYPC, rapid evolution
mediated by interactions between GPC and P. falciparum
EBA140, seems a more likely explanation for the observed
evolutionary pattern.
Regardless of the speciﬁc evolutionary model invoked
to explain the rapid evolution of GYPC, our results offer
a possible contributing explanation to the observation that
the virulence of P. falciparum is much higher in humans
than other Apes (Coatney 1971). Recently, it was shown
that the ability of the P. falciparum receptor EBA175 to
bind to Glycophorin A is altered by species-speciﬁc sialic
acid modiﬁcations to the ligand (Martin et al. 2005). Be-
cause of this, EBA175-mediated invasion of P. falciparum
into P. troglodytes erythrocytes is greatly reduced. Our
ﬁnding indicates that the GPC-dependent pathway (medi-
ated by P. falciparum EBA140) is also not a possible route
forP.falciparuminvasionofthechimpanzeeredbloodcell.
GYPC Exhibits a Novel Mechanism of Protein
Innovation
One of our key ﬁndings is that human GYPC recently
evolved the ability to encode GPC, while retaining the abil-
ity to encode GPD. Translation of multiple protein products
from a single transcript through the use of differing start
codons has been termed‘‘leaky translation,’’ a phenomenon
that is known to affect many genes in diverse organisms
(Kozak 2002). The fact that GPC and GPD are products
of leaky translation is well documented and likely is caused
by the stronger Kozak motif associated with the GPD start
codon, despite its downstream position relative to the GPC
stop codon (ﬁg. 2; Le Van Kim et al. 1996). However, the
evolutionarily derived status of this arrangement, and its
restriction to humans, was not previously known.
Our study demonstrates that the evolution of human
GPC occurred through co-option of 5# UTR sequence by
the protein-coding region of the gene. To our knowledge,
this evolutionary pathway of protein diversiﬁcation has not
previously been documented. In fact, the pattern shown by
GYPC suggests that leaky translation may be a general
hallmark of recent protein innovation. Formation of a novel
upstream codon can cause the expression of a new peptide
while maintaining limited production of ancestral proteins.
In some instances, leaky translation may represent a tran-
sient state as a gene shifts from encoding an ancestral to
a derived protein. In other cases, selection may favor con-
tinued production of both proteins at the gene (mediated by
maintenance of a stronger Kozak motif associated with
downstream codons, for instance). It is unclear which of
these cases applies to GYPC in humans. Regardless, we
believe that the widespread occurrence of leaky translation
among genes and organisms suggests that co-option of
UTR sequence may represent a signiﬁcant evolutionary
pathway by which protein innovation occurs.
Conclusions
GYPC has been subject to positive selection in the
human lineage, leading to both extensive amino acid
Molecular Evolution of GYPC 2685divergence from nonhuman primates and patterns of poly-
morphism consistent with a recent hitchhiking event. These
data are consistent with selection for evasion of
P. falciparum parasites subsequent to the evolution of
a novel protein product (GPC) in humans. Beyond showing
an interesting pattern of adaptive evolution, GYPC also
demonstratesanovelmechanismbywhichproteindiversity
can evolve: capture of UTR sequence following the forma-
tionofanovelstartcodon.Thisprocessleadstoleakytrans-
lation of proteins from multiple initiation sites. We suggest
that leaky translation may be maintained when continued
production of both proteins is beneﬁcial or may represent
an evolutionarily transient state asa gene shiftsfrom encod-
ing an ancestral to a novel derived protein. In either case,
UTR capture offers a potential means by which major pro-
tein innovation can occur through mutation of only a single
nucleotide site.
Supplementary Material
Supplementary materials 1 and 2 are available at
Molecular Biology and Evolution online (http://
www.mbe.oxfordjournals.org/).
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